Sera Prognostics (SERA) Operating Margin Growth (5y) (2025 - 2026)
Sera Prognostics (SERA) Operating Margin Growth (5y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.84 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.95 Bn | 99.73 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.97 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Sera Prognostics | 102.28 Mn | 102.28 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.05 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 3.68 Mn |
| Jun 30, 2025 | 1.65 Mn |